Where Every Dollar Goes in the Drug Supply Chain 

When you put money into a vending machine, it’s a simple transaction. A dollar goes in and a soda comes out. But put that same dollar into the drug supply chain, and you’d be hard-pressed to find exactly what happens to it, how it’s being used or if you’re even getting your money’s worth. 

That’s why understanding the flow of money in the pharmacy benefit management (PBM) industry is so important. By knowing where each dollar goes, you can better decide if your PBM is making decisions in your interest or its own. 

Let’s break it down across three key segments: stakeholders, the flow of a dollar, and finally, how opacity and spread most often occur.

Who are the stakeholders?

Drug manufacturers develop medications and set the initial list price. 

Group purchasing organizations (GPOs) negotiate lower prices for hospitals and pharmacies. 

Wholesalers buy drugs from manufacturers and ship them to pharmacies and health systems. 

Pharmacy services administrative organizations (PSAOs) help small pharmacies with paperwork and deals.

Pharmacy benefit managers (PBMs) work with payers to manage drug benefits, decide what’s covered and negotiate rebates. 

Health plans/Payers decide what drugs are covered and how much members will pay.

Pharmacies dispense medications and ensure safe, timely access for patients. 

Patients are the reason the entire drug supply chain exists.

Where does every dollar go? 

A portion goes to the manufacturer for the drug itself. Wholesalers take a small cut for distribution. Pharmacies take a dispensing fee. Traditional PBMs often retain spread pricing and rebates, adding opacity to the process and leading into the next section. 

Illustration of a one-dollar bill divided into sections showing where prescription drug costs go: a portion to the manufacturer, a small cut to wholesalers for distribution, a dispensing fee to pharmacies, and traditional PBMs retaining spread pricing and rebates.

How do opaque practices like spread pricing work? 

When a client has questions about the opaque PBM practices that cost them unknown amounts of money, it’s usually about things like spread pricing and rebate retention. Instead of being spelled out in contracts or bills, these traditional PBMs use hidden margins to inflate costs or hide the true value of rebates, making it harder to know where the money really goes. 

Conversely, as a pass-through PBM, Navitus changes the game by bringing transparency to every dollar in four key ways: 

  • Ensuring all rebates are passed on to the client 
  • Offering complete visibility and disclosure of all manufacturer financial benefits 
  • Making all manufacturer agreements fully auditable by clients 
  • Going beyond the minimum savings guarantee: as we negotiate better terms, we deliver the full value to you to maximize your savings, not our margins 

Learn more about how our transparent PBM model is designed, so you won’t have any questions about where your dollars go. Reach out to [email protected]

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navigating with a trusted partner

Now Available: 9th Annual Drug Trend Report

Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.

Related blogs

Navigating Healthcare and Improving Outcomes

PBM 101: Demystifying the Complex World of Specialty Drugs

PBM 101: Demystifying the Complex World of Specialty Drugs

Unless you work in the pharmacy benefit management (PBM) industry, it’s easy to assume that a “specialty drug” is simply a more expensive prescription. In reality, specialty medications sit in a separate category, with different rules and far bigger consequences…

previous arrow
next arrow